Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

Share Price is delayed by 15 minutes
Get Live Data
759.50    8.50 (1.13%)
Bid:
758.50
Ask:
760.50
Spread: 2.00 (0.264%)
Market Cap: £865.38m
FEVR Live PriceLast checked at - London Stock Exchange

Intraday Fevertree Share Chart

Trading Update

24 Jan 2018 07:00

RNS Number : 7223C
Fevertree Drinks PLC
24 January 2018
Β 

24th January 2018

Fevertree Drinks plc

Β ("Fever-Tree", the "Group" or the "Company")

Β 

Trading Update

Fever-Tree, the world's leading supplier of premium carbonated mixers, is pleased to announce its trading update for the year ended 31 December 2017.

The Company has delivered another period of very strong growth with full year revenue expected to be circa Β£169 million, reflecting growth of 66% on 2016 with sales in the second half expected to be ahead of the prior year period by 58%.

The performance in the UK in the second half of 2017 has once again been exceptionally strong. The Company gained significant market share from its competitors culminating in Fever-Tree ending the year as the number one mixer brand by value in the UK off-trade channel. (IRI - Total UK Retail Mixer Market value share - 13 weeks to 31/12/17).

Full year revenue in the UK is expected to be circa 96% ahead of 2016. The Group's performance over the Christmas period was particularly notable with impressive rate of sales growth across all channels, formats and flavours. The growth of the mixer category continues to accelerate, driven by Fever-Tree's unwavering focus on quality and supported by the on-going premiumisation of the wider spirits sector.

Sales in Continental Europe performed well in the second half of 2017, and it is anticipated that full year revenue will be circa 42% ahead of 2016.

In the USA, strong revenue growth also continued during the second half of 2017, and as a result, full year revenue for the territory is expected to be circa 39% ahead of 2016. The establishment of a North American office and the appointment of Charles Gibb as North American CEO, announced in December 2017, were significant milestones and reflect the Group's ambition and commitment to the North American market.

Rest of World sales growth accelerated in the second half of 2017 and full year revenue is expected to be circa 57% ahead of 2016.

In view of the Company's very strong sales performance in the final two months of the year, the Group took the opportunity to bring forward planned operational expenditure in the US to invest ahead of growth. Year-end net cash position is anticipated to be in line with Board expectations with significant cash balances still to collect given the strength of trading over the Christmas period.

FY17 expectations

Reflecting the continued strong performance through to the end of the year, the Board expects that the outcome for the full year will be comfortably ahead of market expectations.

Fever-Tree will announce its Preliminary Results on 13th March 2018.

Commenting on today's announcement, Tim Warrillow, Co-founder and CEO of Fever-Tree said:

"I am very proud of our performance in 2017 which has seen Fever-Tree end the year as the number one mixer brand at UK retail. Our pioneering approach and commitment to providing consumers with the highest quality range of mixers continues to capture peoples' imagination and is transforming the wider UK mixer category which as a result is now the fastest growing category across the soft drinks sector.

While we have seen strong growth across all regions, our performance in the UK over the Christmas period was once again exceptional. Our growing range of mixers and formats are appealing not only to our loyal customers but also bringing consumers back to the category and importantly attracting a new younger audience.

There is clear evidence that the same trends of premiumisation and mixability that we've previously highlighted are accelerating and we are increasingly excited by the global opportunity this presents particularly as we transition to our own operations in the US."

Β 

Β 

For further information:

Β 

Fevertree Drinks plc

Tim Warrillow, Co-founder and CEO

Andy Branchflower, Finance Director

Oliver Winters, Communications Director

+44 (0)20 7349 4922

FTI Consulting - Financial PR

Jonathon Brill

Georgina Goodhew

Fiona Walker

+44 (0)20 3727 1000

fever-tree@fticonsulting.com

Investec Bank plc - Nominated Adviser and Broker

Garry Levin

Alex Wright

David Anderson

+44 (0)20 7597 5970

Β 

Β 

Notes to Editors:

Β 

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 60 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTLLFFALIIVFIT
Date   Source Headline
9th Jun 20205:02 pmRNSBlock Listing Return
4th Jun 20203:58 pmRNSResult of AGM
4th Jun 20207:00 amRNSAGM STATEMENT & COVID-19 UPDATE
28th May 20205:00 pmRNSGrant of Options
11th May 20204:37 pmRNS2019 Annual Report and Notice of AGM
29th Apr 20207:00 amRNSDirectorate Change
28th Apr 20204:13 pmRNSTR1: Notification of Major Holdings
23rd Apr 202012:15 pmRNSDirector/PDMR Shareholding
22nd Apr 20207:00 amRNSPreliminary Results
14th Apr 20202:30 pmRNSNotification of Results
8th Apr 20204:14 pmRNSStandard form for Notification of Major Holdings
23rd Mar 202010:59 amRNSFCA letter re Release of Preliminary Results
27th Feb 20207:00 amRNSNotification of Major Holdings
11th Feb 20206:04 pmRNSTR-1: Notification of Major Holdings
10th Feb 20207:00 amRNSDirector/PDMR Shareholding
28th Jan 20205:23 pmRNSTR1: Notification of Major Holdings
23rd Jan 20204:34 pmRNSTR-1: Notification of major holdings
23rd Jan 20207:00 amRNSDirector/PDMR Shareholding
22nd Jan 20204:35 pmRNSTR-1: Notification of major holdings
22nd Jan 202012:15 pmRNSTR-1: Notification of major holdings
20th Jan 20207:00 amRNSYear End Trading Update
8th Jan 20202:19 pmRNSNotification of major holdings
3rd Jan 20203:31 pmRNSTR-1: Standard form notification of major holdings
29th Nov 20197:00 amRNSDirector Disclosure
20th Nov 20197:00 amRNSTrading Update
18th Nov 20197:00 amRNSDirector/PDMR Shareholding
6th Nov 20195:43 pmRNSBlock Listing Return
16th Aug 201912:55 pmRNSDirector/PDMR Shareholding
25th Jul 20194:11 pmRNSDirector/PDMR Shareholding
23rd Jul 20197:00 amRNSInterim Results
4th Jun 20194:35 pmRNSTotal Voting Rights
24th May 20195:11 pmRNSResult of Annual General Meeting
24th May 20197:00 amRNSAGM Statement
23rd May 20197:00 amRNSBlock Admission Application
1st May 20198:44 amRNSBlock Listing Return
23rd Apr 20197:00 amRNS2018 Annual Report and Notice of AGM
3rd Apr 20195:03 pmRNSNotification of Major Holdings
29th Mar 20198:31 amRNSNotification of Major Holdings
26th Mar 20197:00 amRNSPreliminary Results
12th Feb 20195:47 pmRNSDirector/PDMR Shareholding
24th Jan 20197:00 amRNSTrading Update
11th Jan 20197:00 amRNSNotification of Trading Update
7th Dec 20187:00 amRNSDirector/PDMR Shareholding
1st Nov 20183:34 pmRNSHolding(s) in Company
31st Oct 201810:16 amRNSBlock Listing Return
31st Oct 20187:00 amRNSAppointment of Nomad and Joint Broker
19th Oct 20188:12 amRNSHolding(s) in Company
16th Oct 20185:16 pmRNSHolding(s) in Company
11th Oct 20187:00 amRNSDirector/PDMR Shareholding
31st Aug 201810:40 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.